Childhood Acute Promyelocytic Leukemia (M3)

7 clinical trials · Condition

Record	Firm	Date
Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia (NCT01146223)	Children's Oncology Group	2009-09-01
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia (NCT00217412)	National Cancer Institute (NCI)	2005-08-01
Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia (NCT00077467)	National Cancer Institute (NCI)	2004-01-01
Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT00042796)	National Cancer Institute (NCI)	2002-12-01
Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia (NCT00003934)	National Cancer Institute (NCI)	1999-06-01
High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma (NCT01177371)	Case Comprehensive Cancer Center	1988-03-01
Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia (NCT01869803)	Wake Forest University Health Sciences

Every clearance here is in the API, with alerts when new ones post.